WPRIM Management System> DCMS> Chinese Journal of Clinical Oncology> 2019> 46

Volume: 46

1. Correlation of lymphatic vessel density with a high mobility group Box-1 protein and tumor-associated macrophages in cervical carci-noma Page:222—226
2. Evolution and control of errors in precision radiotherapy of lung cancer Page:276—279
3. Research development of Aurora-A kinase Page:272—275
4. Research progress of stem cell gene Musashi-1 Page:269—271
5. Clinical experience on breast fiberoptic ductoscopy from 1 368 re-ported cases of patients with breast intraductal lesion Page:254—258
6. Evaluation of esophageal regeneration in cancer research Page:219—221
7. A case study of cancer-associated VTE:diagnosis and treatment strategies Page:262—265
8. Syndrome of inappropriate anti-diuretic hormone in lung-cancer patients:six cases Page:259—261
9. No postoperative survival benefit in concurrent chemoradiation treated patients with low-risk early-stage cervical squamous cell carcinoma Page:242—245
10. Expression and clinical significance of CCNG2 in glioblastoma pa-tients Page:237—241
11. Clinico pathologic characteristics and molecular phenotypes of young breast cancer patients and their clinical significance Page:231—236
12. Advances in oncolytic adenovirus-loaded mesenchymal stem cells for treating tumors Page:266—268
13. The status of glucose intolerance in breast cancer patients without DM history after systemic treatment with surgery and/or chemo-therapy Page:250—253
14. Efficacy analysis of Jin Long Capsule (JLC) in neoadjuvant chemotherapy of breast cancer Page:246—249
15. Influence and significance of DHA on expression of angiogene-sis-related genes in SGC7901 cells Page:227—230
16. Research progress in targeted immunotherapy combined with ra-diotherapy for stageⅢ/Ⅳmelanomas Page:255—258
17. Comparison of efficacy of induction chemotherapy plus intensi-ty-modulated radiotherapy and concurrent chemo-radiotherapy plus adjuvant chemotherapy for patients with loco-regionally ad-vanced nasopharyngeal carcinoma Page:231—235
18. Clinical and hematological features of malignant lymphoma com-bined with venous thromboembolism Page:226—230
19. Reasons and surgical strategy for unplanned resection of 23 soft tissue sarcoma cases Page:212—216
20. BMP4 promotes migration and invasion of hepatocellular carcinoma by inducing epithelial-mesenchymal transition Page:207—211
21. Correlation between anaplastic lymphoma kinase and pediatric malignancies Page:251—254
22. Gallbladder sarcomatoid carcinoma:six cases and literature review Page:247—250
23. Prognostic values of tumor-stroma ratio and tumor-infiltrating lymphocytes in stagesⅡandⅢcolorectal cancer Page:241—246
24. Survival analysis of 256 patients with oral cancer Page:217—221
25. Development of Chinese gastric cancer surgery: opportunities and challenges Page:2—5
26. Research advances in preoperative staging of gastric cancer Page:6—11
27. Indications for total laparoscopic proximal gastrectomy and the following selection of gastrointestinal reconstruction methods Page:12—15
28. Research progress in the molecular epidemiology of gastric cancer Page:16—21
29. Clinical value of standardized procedures of fine lymph node sorting from gastric can-cer samples after curative resection: a study of 727 cases Page:22—27
30. Analysis of clinicopathological characteristics and prognostic factors of gastric stump cancer in 105 patients Page:28—33
31. Safety analysis of implanted peritoneal ports in gastric cancer with peritoneal metastasis Page:34—38
32. Histogram analysis of apparent diffusion coefficient with multi-b-value DWI at 3.0T MRI: correlation with prognostic factors and subtypes of breast cancer Page:39—43
33. Research progress of PD-1/PD-L1 in small cell lung cancer Page:44—48
34. Progress in the diagnosis and treatment of synchronous multiple gastric cancer Page:64—68
35. Clinicopathological characteristics of gastric cancer with enteroblastic differentiation Page:69—72
36. TCT and hrHPV analysis of 318 cases with high-grade cervical intraepithelial neoplasia and cervical cancer Page:73—76
37. Clinical value of peripheral regulatory cells in patients with non-small cell lung cancer undergoing radiotherapy Page:77—82
38. Clinical observation of bevacizumab combined with pemetrexed for patients with re-current metastatic cervical cancer Page:83—85
39. Effect of different doses of naloxone combined with dezocine on postoperative analge-sia in patients with breast cancer Page:86—89
40. Causes of death in patients with lymphoma during long-term follow-up Page:90—93
41. Advances in the clinical applications of large panel high-throughput sequencing in tu-mors Page:94—98
42. Research progress of intraperitoneal hyperthermic perfusion chemotherapy after ad-vanced gastric cancer operation Page:99—102
43. SVEP1, PKHD1, and P53 expression in primary liver cancer and its clinical significance Page:105—110
44. Clinical significance of GCNT3 expression in non-small cell lung cancer Page:111—116
45. The expression of microRNA-145 in cervical cancer and its inhibitory effects on Wnt/β-catenin signaling pathway Page:117—121
46. Clinical observation of laparoscopic abdominoperineal intersphincteric resection com-bined with ileostomy for treatment of ultra-low rectal cancer Page:122—125
47. Vascular anatomy of the stomach and its application in gastric tube reconstruction dur-ing esophagectomy Page:126—129
48. Clinical analysis of retroperitoneal and transperitoneal laparoscopic radical nephroure-terectomy for upper urinary tract urothelial carcinoma Page:130—132
49. Comparison of the efficacy and safety of cisplatin, etoposide, and irinotecan combined with chemotherapy and topotecan monotherapy as second-line treatment for patients with sensitive relapsed SCLC Page:133—137
50. Analysis of survival and prognostic factors of patients with intracranial ependymoma Page:138—144
51. Epidemiology of cancer in China and the current status of prevention and control Page:145—149
52. Research advances of chromosomal 8q24 aberrance in breast cancer Page:150—153
53. Application of mRNA in tumor immunotherapy Page:154—158
54. Epstein-Barr virus BZLF1 promotes the growth of gastric cancer cells through activa-tion of the PI3K/AKT signaling pathway Page:159—163
55. Effect of NPM1 mutant A on TGF-β1-induced K562 cell proliferation and AKT phos-phorylation Page:164—168
56. Identification of genomic aberrations associated with lymph node metastasis in esoph-ageal squamous cell carcinoma Page:169—172
57. Correlation between TEM1 expression and efficacy of neoadjuvant chemotherapy in patients with gastric cancer Page:173—177
58. Comparison of efficacy and safety of triple-drug treatment regimens for metastatic colorectal cancer Page:178—183
59. Clinical evaluation of drug efficiency in primary malignant bone tumors Page:184—189
60. Accurate analysis of pelvic tumor resection assisted by a three-dimensionally printed acetabular guide plate Page:190—194
61. Progress of hypofractionated radiotherapy after breast-conserving surgery Page:208—211
62. Advances in the treatment of malignant melanoma Page:213—217
63. Effects of thrombopoietin on TGFβ1-induced myofibroblast transdifferentiation in hu-man lung fibroblasts Page:218—222
64. Expression of lncRNA BC200 in non-small cell lung cancer and its significance Page:223—227
65. Effect of cardiovascular comorbidities on the perioperative period of patients with colorectal cancer aged over 80 years Page:233—238
66. Clinicopathological characteristics and prognostic factors of gastric neuroendocrine neoplasms: an analysis of 117 cases Page:239—246
67. Therapeutic choice of axillary treatment after neoadjuvant chemotherapy in patients with node-positive breast cancer Page:247—251
68. Current status and application of endoscopic submucosal dissection for early gastric cancer Page:252—256
69. Role of ROS1 fusion gene mutations in diagnosis and treatment of non-small cell lung cancer Page:257—262
70. TAZ promoting angiogenesis and its mechanism in gastric cancer Page:272—277
71. Anti-tumor experimental study of mouse multi-subtype heat shock protein/peptide vaccine combined with PD-L1 immunological checkpoint inhibitor Page:278—283
72. Investigation of clinicopathological features and indication of endoscopic resection in young patients with intramucosal early gastric cancer Page:284—287
73. Eleven cases of DEB-TACE comprehensive interventional strategy for stage Ⅲa hypo-vascular hepatocellular carcinoma Page:288—292
74. Effect of the preoperative Geriatric Nutritional Risk Index on the prognosis of patients with esophageal squamous cell carcinoma after radical resection Page:293—298
75. Risk factors for positive surgical margin after laparoscopic radical prostatectomy Page:299—302
76. Effect of whole-brain radiotherapy and TKIs on suvival of patients with brain metastases from non-small cell lung cancer stratified by EGFR mutation status Page:303—310
77. Advances of CLDN18.2 protein in the therapy of malignant tumors Page:311—315
78. Expression of KIF20A and its clinical significance in colorectal cancer Page:324—329
79. Impact of perineural invasion on the overall survival of patients with gastric cancer Page:330—336
80. Prediction model for distant metastasis of breast cancer based on magnetic resonance imaging Page:337—341
81. Clinical features and prognosis of intracranial embryonal tumors in children Page:342—345
82. Diagnosis and prognosis of cervical lymph node metastases of squamous cell carcino-ma of unknown primary site Page:346—350
83. Application of 125I radioactive particles in mediastinal lymph node metastasis Page:351—356
84. The clinical application of the open supraclavicular approach in thyroidectomy Page:357—360
85. Implication of BRCA1/2 gene detection in malignant tumors Page:361—365
86. Research progress on the novel glutaminase inhibitor and its antitumor activity Page:366—369
87. Updates and prospect of da Vinci robotic surgical system in radical resection of colorectal cancer Page:370—374
88. Cancer control based on six integrations Page:375—377
89. The effect of entinostat on NK killing effect on non-small cell lung cancer in vitro Page:378—383
90. Application of SM-PCR to detect plasma ctDNA in the treatment of patients with ad-vanced lung adenocarcinoma Page:384—388
91. Correlation between tumor-infiltrating lymphocytes and the androgen receptor in HER-2-positive breast cancer Page:389—393
92. External validation of the ABC scoring system in minimally invasive partial nephrectomy Page:394—398
93. Impact of portal hypertension and hypersplenism on prognosis of hepatocellular carci-noma after curative treatment Page:399—405
94. Measurement of the distance of microfoci from a rectal gross tumor in a pathological specimen Page:406—411
95. Multidisciplinary treatment discussion of a personalized approach of laparoscopic right hemicolectomy for variant middle colic artery and ileocolic vein Page:412—415
96. Advances in the application of iron oxide based magnetic nanoparticles in cancer ther-anostics Page:416—420
97. Research progress in Xp11 translocation renal cell carcinoma Page:421—423
98. Interpretation of guideline for breast cancer screening in Chinese women Page:433—441
99. The progress of immunotherapy for hepatocellular carcinoma Page:442—447
100. Causes of death in 1,173 patients with lymphoma Page:448—452
101. Change of peripheral blood sPD-L1 during chemotherapy in patients with small cell lung cancer and its clinical significance Page:453—457
102. Application of digital angle instrument in computed tomography-guided percutaneous lung biopsy Page:458—462
103. The clinical value of endobronchial ultrasound elastography in the diagnosis of medias-tinal and hilar lymph nodes Page:463—467
104. Incidence and mortality of colorectal cancer in Jiangsu province in 2015 Page:468—473
105. Current status and controversy of neoadjuvant therapy for esophageal squamous cell carcinoma Page:474—479
106. Technological progress in intraoperative rapid identification of the parathyroid glands Page:480—484
107. Expression of CD30 and its correlation with prognosis of patients with peripheral T cell lymphoma, unspecified Page:485—489
108. Detection of plasma HOXA7 methylation in the diagnosis of non-small cell lung cancer Page:490—494
109. Clinicopathological features and prognostic factors of patients with bone-only metas-tases Page:495—500
110. Patterns of locoregional rectal cancer recurrences after total mesorectal excision and delineation of the radiotherapy clinical target volume Page:501—506
111. Role of prophylactic supraclavicular irradiation in high-risk patients with limited-stage small-cell lung cancer Page:507—512
112. Risk factors and pathogen analysis of candidemia in cancer patients Page:513—517
113. Research progress and new ideas in circadian gene Bmal1 and oncotherapy Page:518—523
114. Research progress in mechanisms of tumor-associated neutrophils promoting tumor metastasis Page:524—527
115. Current status of synthetic lethality effects in cancer research Page:528—532
116. Advances in dual-targeted therapy for HER2-positive breast cancer based on trastu-zumab Page:533—536
117. Application status of commonly used patches in breast reconstruction Page:537—540
118. Advance in diagnosis and treatment of idiopathic multicentric Castleman disease Page:541—545
119. Potential advantages of robot-assisted gastrectomy over laparoscopy-assisted gastrec-tomy regarding lymphadenectomy for gastric cancer Page:546—550
120. Experimental animal models of pancreatic carcinogenesis and liver metastasis and me-tastasis-related molecules Page:551—556
121. Risk factors for cervical nodal metastasis in patients with papillary thyroid carcinoma Page:557—561
122. Prognosis and efficacy of neoadjuvant chemotherapy in patients with invasive micro-papillary carcinoma of breast Page:562—567
123. Prognostic value of CT characteristics in crizotinib-treated patients with advanced non-small cell lung cancer Page:568—574
124. Research progress in the treatment of cancer patients with positive NTRK gene fusion with larotrectinib Page:575—580
125. Advances in targeted drug therapy for relapse/refractory diffuse large B-cell lymphoma Page:581—585
126. The mechanism and progress of PARP inhibitors in the treatment of advanced breast cancer Page:586—588
127. Advances in the relationship between gene mutation status and cancer-associated ve-nous thrombosis Page:589—594
128. Expression of Erbin in esophageal squamous cell carcinoma and its relationship with patient prognosis Page:595—600
129. Correlation between MRI features and tumor risk grade in gastrointestinal stromal tumors Page:601—605
130. Retrospective analysis of clinical characteristics and prognostic factors of primary breast diffuse large B-cell lymphoma Page:606—610
131. Improved intercostal nerve block with ropivacaine in video-assisted thoracic surgery Page:611—614
132. Clinical application of apatinib in the treatment of advanced bone and soft tissue sar-coma Page:615—621
133. Effect of subventricular zone invasion on prognosis of glioma patients Page:622—626
134. Evaluation of efficacy and safety of apatinib for patients with recurrent epithelial ovari-an cancer Page:627—630
135. Advances in research of E26 transforming specific homologous factor EHF/ESE3 in tu-mors Page:631—635
136. Advances in radiotherapy for extensive-stage cell lung cancer Page:636—639
137. The function of long non-coding RNA in the occurrence and development of multiple myeloma Page:640—644
138. The clinical significance of MGMT promoter methylation in the treatment and progno-sis of glioma patients Page:645—648
139. Advances in targeted therapy for triple-negative breast cancer Page:649—652
140. Imaging features of primary adenoid cystic carcinoma of the breast Page:661—664
141. Application of 3D imaging technology in preoperative evaluation of breast conserving surgery Page:665—668
142. Features of CT imaging and clinicopathological characteristics in multilocular cystic re-nal neoplasm of low malignant potential and cystic nephroma Page:669—672
143. Diagnosis and prognosis of adrenocortical carcinoma in children Page:673—677
144. Clinical efficacy of complete mesocolic excision in the emergency surgery for patients with colon cancer Page:678—681
145. Validation of the Caprini risk model for predicting deep venous thrombosis in hospital-ized patients with malignant tumors Page:682—685
146. The crosstalk between immunosenescence and tumor pathogenesis Page:686—689
147. Research and application progress of circulating tumor cells in hepatocellular carcinoma Page:690—693
148. Current status of immunotherapy and targeted therapy for intrahepatic cholangiocarcinoma Page:694—699
149. Advances of hypoxia-induced chemotherapy resistance in gastric cancer Page:700—703
150. Advances in the treatment of patients with stageⅡ-ⅢA non-small cell lung cancer and the EGFR mutation Page:707—711
151. Expression and function of lncRNA BDNF-AS in breast cancer Page:712—717
152. Expression and mechanism of microRNA-613 in breast cancer Page:718—722
153. Expression and potential role of ajuba LIM protein in oral squamous cell carcinoma Page:723—727
154. Clinicopathological characteristics and prognostic factors of 83 patients with ovarian metastasis from gastric cancer Page:728—733
155. A combination of lenalidomide, bortezomib, and dexamethasone (RVD) provides deep-er responses in patients with newly diagnosed multiple myeloma Page:734—738
156. Efficacy and safety of PEG-rhG-CSF therapy in the primary and secondary prevention of chemotherapy-induced neutropenia Page:739—744
157. Research advances of tRNA-derived fragments in tumors Page:745—749
158. Clinical management of common adverse effects of ibrutinib Page:750—754
159. Homing barriers and solutions for CAR-T cells in the treatment of solid tumors Page:755—759
160. Effects of hypoxia on adiponectin in tongue squamous cell carcinoma Page:815—821
161. Effect of body mass index on the number of lymph nodes harvested in patients who underwent colorectal cancer resection Page:822—826
162. Impact of visceral obesity on the short-term outcomes after radical operation for mid-low rectal cancers Page:827—831
163. Comparison of efficacy between early enteral nutrition and total parenteral nutrition after esophageal cancer surgery based on propensity score matching Page:832—835
164. Risk factors for hepatocellular cancer occurrence in patients with primary biliary cholangitis Page:836—840
165. Clinical and pathological features of 50 cases of double primary cancer in the stomach and colorectum Page:841—844
166. Clinical efficacy of apatinib for metastatic castration-resistant prostate cancer Page:845—850
167. Economic evaluation of breast cancer screening for Chinese urban women Page:851—856
168. Advances of toripalimab for the treatment of melanoma Page:857—860
169. Significance of alternative splicing in drug resistance of chronic myeloid leukemia Page:861—864
170. Progress of transcriptomics and proteomics in triple-negative breast cancer prognosis assessment Page:865—868
171. Clinical characteristics and prognosis of metastatic papillary renal cell carcinoma Page:883—886
172. Clinicopathological analysis of ovarian pseudomyxoma peritonei Page:887—890
173. Impact of tumor deposits on the prognosis of gastric cancer patients Page:891—896
174. Diagnosis and treatment of pseudomyxoma peritonei of extra-appendiceal origin:analysis of 34 cases Page:897—902
175. The prognostic value of prognostic nutritional index in patients with diffuse large B-cell lymphoma Page:903—908
176. Study of EGFR mutation status in multiple pulmonary ground-glass nodules Page:909—913
177. Research progress on osteosarcoma treatment in the precision medicine era Page:914—918
178. A multi-disciplinary treatment strategy involving oncology subdisciplines and consul-tation-liaison multi-disciplinary for the comprehensive management of concomitant diseases of breast cancer Page:919—922
179. Influence of the immunosuppressive microenvironment in pancreatic cancer on chemo-resistance Page:969—973
180. The progress of targeted agents for HER-2 positive breast cancer Page:965—968
181. Advances in the study of apatinib-induced hand-foot skin reaction Page:962—964
182. Research advances of oncolytic viruses promoting autophage in tumor cells Page:957—961
183. Laparoscopic transabdominal ultra-low anastomosis for rectal cancer: experience of 54 cases Page:953—956
184. Efficacy of apatinib plus pemetrexed for advanced non-squamous non-small cell lung cancer in elderly patients Page:949—952
185. Clinical analysis of third-line combination therapy with S-1 plus apatinib for advanced colorectal cancer Page:945—948
186. Clinicopathological features and prognostic analysis of initially diagnosed stage Ⅳ breast cancer bone metastasis Page:940—944
187. Construction of a prognostic nomogram model for patients with rhabdomyosarcoma Page:934—939
188. Efficacy and influence factors of concurrent radiotherapy and chemotherapy for high-grade brainstem glioma Page:930—933

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.